{"SPADE_UN_00942": {"Clinical Information": [], "Patent Information": [{"Patent No": "US 2004/0019181 A1", "Patent Link": "http://www.lens.org/lens/patent/US_2004_0019181_A1", "Patent Type": "Patent Application", "Publication Date": "2004-1-29", "Family Info": "CA2230160A1,DE69637731D1,EP0846128A2,EP0846128B1,US6191254,US7390873,WO1997008199A2,WO1997008199A3", "Patent Title": "Antimicrobial cationic peptides.", "Abstract": "A novel class of cationic peptides having antimicrobial activity is disclosed. These peptides can be encompassed by the formulas: X 1 X 1 PX 2 X 3 X 2 P(X 2 X 2 P) n X 2 X 3 (X 5) 0; (SEQ ID NO: 23) X 1 X 1 PX 2 X 3 X 4 (X 5) r PX 2 X 3 X 3; (SEQ ID NO: 24) X 1 X 1 X 3 (PW) u X 3 X 2 X 5 X 2 X 2 X 5 X 2 (X 5) 0; and (SEQ ID NO: 25) X 1 X 1 X 3 X 3 X 2 P(X 2 X 2 P) n X 2 (X 5) m; (SEQ ID NO: 26) wherein: m is 1 to 5; n is 1 or 2; o is 2 to 5; r is 0 to 8; u is 0 or 1; X 1 is Isoleucine, Leucine, Valine, Phenylalanine, Tyrosine, Tryptophan or Methionine; X 2 represents Tryptophan or Phenylalanine X 3 represents Arginine or Lysine; X 4 represents Tryptophan or Lysine; and X 5 represents Phenylalanine, Tryptophan, Arginine, Lysine, or Proline. The invention also provides a method of producing a cationic peptide variant having antimicrobial activity."}, {"Patent No": "US 6191254 B1", "Patent Link": "http://www.lens.org/lens/patent/US_6191254_B1", "Patent Type": "Granted Patent", "Publication Date": "2001-2-20", "Family Info": "US4810777,US5547939,US5635594,CA12060510,EP0356409,WO8911290,WO9522338", "Patent Title": "Antimicrobial Cationic Peptides", "Abstract": "A novel class of cationic peptides having antimicrobial activity is disclosed. These peptides can be encompassed by the formulas, wherein, m is 1 to 5; n is 1 or 2; o is 2 to 5; r is 0 to 8; u is 0 or 1; X1 is Isoleucine, Leucine, Valine, Phenylalanine, Tyrosine, Tryptophan or Methionine; X2 represents Tryptophan or Phenylalanine\n X3 represents Arginine or Lysine;  X4 represents Tryptophan or Lysine; and X5 represents Phenylalanine, Tryptophan, Arginine, Lysine, or Proline. The invention also provides a method of producing a cationic peptide variant having antimicrobial activity."}], "Sequence Information": {"SPADE ID": "SPADE_UN_00942", "Sequence": "ILPWKWPWWPWRRWR", "Sequence Length": 15, "Peptide Name": "Sequence 7 from Patent US 20040019181", "Source": "Synthetic construct", "Biological Activity": ["Antimicrobial"], "Frequent Amino Acids": "WPR", "Absent Amino Acids": "ACDEFGHMNOQSTUVY", "Basic Residues": 4, "Acidic Residues": 0, "Hydrophobic Residues": 11, "Polar Residues": 4, "Positive Residues": 4, "Negative Residues": 0, "Mass": 2249.66, "PI": 12.0, "Net Charge": 4, "Hydrophobicity": -1.29, "Similar Sequences": [{"SPADE_ID": "SPADE_N_02467", "Similarity": 1.0, "Sequence": "ILPWKWPWWPWRR"}, {"SPADE_ID": "SPADE_N_09544", "Similarity": 1.0, "Sequence": "ILPWKWPWWPWR"}, {"SPADE_ID": "SPADE_N_09545", "Similarity": 1.0, "Sequence": "ILPWKWPWWPW"}]}}}